Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN Contributor

Benjamin Conway

Benjamin Conway is founder and Managing Director of Johnston Blakely & Company, LLC. Johnston Blakely & Company is a Boston-based investment bank focused exclusively on the life sciences. Mr. Conway was previously head of biotechnology banking for Adams, Harkness & Hill where was involved in transactions with a cumulative value of over $1 billion. His prior experience also includes Abbott Laboratories and Bain & Company as well as two biotech start-ups, one of which, Gamera Bioscience, he co-founded. Mr. Conway graduated magna cum laude from Bowdoin College and received an M.B.A., with honors, from the Harvard Business School.

More GEN Content From This Contributor:

GEN Articles

More GEN Content From This Contributor:

GEN Podcasts

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »